← Leaderboards
James N Bates
Atelerix Life Sciences Inc.
$1,836,983
Attributed
$1,836,983
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $928.5K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,836,983 · 1
By mechanism
R44$1,836,983 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Absence Of Pain Sensation”
- Sid Ahmed Labed · Evodenovo, Inc.$2,230,338
- Cameron Reid Smith · University Of Florida$1,762,231
- Katharina Maria Busl · University Of Florida$1,762,231
- Grace Lim · University Of Pittsburgh At Pittsburgh$1,677,192
- Alejandra Mendoza · Scripps Research Institute, The$1,656,000
- Judy Ashworth · Sparian Biosciences, Inc.$1,569,016
Research focus
Absence Of Pain SensationAnalgesicsAnalytical MethodAdultAnimalsBiological SciencesCanis FamiliarisCaringAnesthesia ProceduresClinical TrialsCollaborationsComplicationCostCyclic GmpCyp1a2 GeneCyp2b6 GeneCyp3a4 GeneCystineCytochrome P450DesignDoseDrug DevelopmentDrug DiscoveryDrug Interactions
Grant awards (2)
Development of Sudaxine for the Treatment of Opioid Induced Respiratory Depression (OIRD) in the Peri-operative Hospital Setting$928,464
R44 · FY2023 · HL · contact PI
Development of Sudaxine for the Treatment of Opioid Induced Respiratory Depression (OIRD) in the Peri-operative Hospital Setting$908,519
R44 · FY2022 · HL · contact PI